TBX20 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the TBX20 protein, a member of the T-box family of transcription factors. TBX20 plays a critical role in regulating gene expression during developmental processes, particularly in the formation and function of the heart, as well as in other tissues. T-box proteins, including TBX20, are characterized by their conserved DNA-binding domain, which allows them to regulate the transcription of genes involved in cell differentiation, proliferation, and pattern formation during embryonic development. By inhibiting TBX20, these compounds interfere with the protein's ability to bind to specific DNA sequences, resulting in the disruption of the transcriptional regulation of genes under its control, leading to changes in cellular behavior and development.
Research into TBX20 inhibitors is essential for understanding the role of TBX20 in developmental biology, as well as the gene regulatory networks it controls. By inhibiting TBX20, scientists can study the downstream effects of altered transcription on cellular processes such as tissue morphogenesis, differentiation, and the maintenance of organ function. TBX20 inhibitors also provide insights into how transcription factors from the T-box family coordinate developmental cues with the regulation of gene expression patterns, ensuring that cells differentiate and develop appropriately within an organism. The use of these inhibitors in research helps elucidate the molecular mechanisms by which TBX20 interacts with other proteins and transcription factors to influence complex gene expression programs. Overall, TBX20 inhibitors are valuable tools for studying the intricate regulatory roles of transcription factors in development and their contributions to cellular identity and function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
KY02111 | 1118807-13-8 | sc-397043 sc-397043A | 5 mg 25 mg | $79.00 $336.00 | ||
KY02111 targets the Wnt/β-catenin pathway, indirectly affecting TBX20. It inhibits the phosphorylation of DVL2, a key player in Wnt pathway signaling. | ||||||
XAV939 | 284028-89-3 | sc-296704 sc-296704A sc-296704B | 1 mg 5 mg 50 mg | $35.00 $115.00 $515.00 | 26 | |
XAV-939 is a tankyrase inhibitor that stabilizes Axin, thus inhibiting the Wnt/β-catenin pathway and potentially impacting TBX20 function. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
Y-27632, a ROCK inhibitor, may indirectly influence TBX20 activity by modulating cytoskeletal dynamics and cell signaling pathways that can intersect with TBX20's role in cardiac development. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
PD173074, a FGFR inhibitor, can indirectly affect TBX20 by modulating fibroblast growth factor signaling, which is involved in cardiac development and may intersect with TBX20 pathways. | ||||||
GSK-3 Inhibitor IX | 667463-62-9 | sc-202634 sc-202634A sc-202634B | 1 mg 10 mg 50 mg | $57.00 $184.00 $867.00 | 10 | |
BIO is a GSK-3 inhibitor that activates the Wnt/β-catenin pathway. By modulating this pathway, BIO can indirectly influence TBX20's role in cardiac gene regulation. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $153.00 $520.00 | 4 | |
CHIR99021 is another GSK-3 inhibitor that activates Wnt/β-catenin signaling, potentially affecting TBX20's regulatory roles in the heart. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542, an inhibitor of the TGF-β receptor, can indirectly impact TBX20 through the TGF-β signaling pathway, which plays a role in heart development. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, may influence TBX20 activity by modulating stress response pathways and cellular processes that intersect with TBX20's function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
LY294002, a PI3K inhibitor, can indirectly affect TBX20 by altering PI3K/Akt signaling, which is involved in numerous cellular processes including cardiac development. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Wortmannin is another PI3K inhibitor that can have an indirect effect on TBX20 activity by modulating PI3K/Akt pathway signaling. | ||||||